缺血性心脏病血流动力学稳定的单形性室速首选导管消融还课件_1

缺血性心脏病血流动力学稳 定的单形性室速：首选导管 消融还是ICD? 中国医科大学第一医院 于 波 持续性单形性室性心动过速 （Sustained monomorphic ventricular tachycardia （SMVT） uA regular wide QRS complex tachycardia at a rate of 100 bpm uThe consecutive beats have a uniform and stable QRS morphology uThe arrhythmia lasts 30 sec or causes hemodynamic collapse uStable SMVT was defined as a VT not leading to cardiac arrest or syncope and SBP 90 mmHg Primary VT 占猝死病人约8.3% Incidence of SMVT after infarction 3% 2008年ACC/AHA/HRS心脏节律异常 器械治疗指南-ICD的I类适应症 u 非可逆性原因导致的 VF或血流动力学不稳定的VT引起的心脏骤停 u伴有器质性心脏病的自发性持续性 VT，无 论血流动力学是否稳定 u 原因不明的晕厥，在电生理检查时能诱发有血液动力学异常的持续性 室速或室颤 u 心肌梗死所致LVEF35%，心肌梗死后40天、NYHA II或III级 u NYHA II或III级LVEF35%，非缺血性心肌病患者 u 心肌梗死所致LVEF30%，心肌梗死后40天、NYHA 级 u 心肌梗死所致非持续性VT，LVEF40%且电生理检查能够诱发出VF 或持续性VT 0.6 0.8 1.01.2 1.4 MADIT-I AVID 1.6 0.4 CABG-Patch MADIT-II 1996 1997 1997 2002 Aborted cardiac arrest N = 196 N = 1016 N = 900 N = 1232 0.46 0.62 1.07 0.69 Hazard ratio ICD better SCD-HeFT N = 1676 2005 0.77 1.8 LVEF, other features 0.35 or less, NSVT, EP positive 0.30 or less, prior MI 0.35 or less, LVD due to prior MI and NICM 0.35 or less, abnormal SAECG and scheduled for CABG CASH* 2000 N = 191 Aborted cardiac arrest DEFINITE 2004 N = 458 0.65 0.35 or less, NICM and PVCs or NSVT CIDS 2000 N = 659 0.82 Aborted cardiac arrest or syncope DINAMIT 2004 N = 674 1.08 0.35 or less, MI within 6 to 40 days and impaired cardiac autonomic function Trial Name, Pub Year 0.83 ICDs: Results from Primary and Secondary Prevention Trials Primary Prevention of SCD in Absence of Ventricular Arrhythmias Primary Prevention of SCD in Ventricular Arrhythmias a prior MI, dec EF and NSVT -ICD provides the lowest mortalitya prior MI, dec EF and NSVT -ICD provides the lowest mortality uICD并非治愈心律失常，术后1年内发生ICD治疗比例二级预防 约40%，一级预防约5-18% uICD虽可挽救生命，反复放电却显著增加心理疾病（发生率 50%），明显降低生活质量，ICD术后同样可以晕厥 u每年5次电击（尤其是电风暴，10-25%）死亡率明显增加 uICD并不能提供由于心律失常原因所致死亡的绝对保护 ，荟萃 分析显示ICD无反应率5%，猝死率30%，这些病人大多死于ICD 放电后的心电机械分离或因为ICD未能终止的VT/VF而致死 u合并器质性心脏病的血流动力学稳定VT病人在植入ICD的随机 研究中未见预后获益 u对所有适应症患者植入ICD因为太贵而不能广泛应用：中国每 年约54万人猝死，年植入不足1500余台，包括CRTD,累计近3300 台，美国每年约45人猝死，年安装ICD也只有近26万台 ICD预防SCD的局限性 预防ICD放电的最好方法是不植入ICD！ Ablation is indicated in pts who are otherwise at low risk for SCD and have sustained predominantly monomorphic VT that is drug resistant or intolerant, or who do not wish long-term drug therapy Ablation is indicated in patients with bundle-branch reentrant VT Ablation is indicated as adjunctive therapy in pts with an ICD who are receiving multiple shocks as a result of sustained VT that is not manageable by reprogramming or changing drug therapy or who do not wish long-term drug therapy Ablation is indicated in patients with WPW syndrome resuscitated from sudden cardiac arrest due to AF and rapid conduction over the accessory pathway causing VF I I I IIaIIa IIa IIb IIb IIb III IIIIII I I I IIaIIa IIa IIb IIb IIb III IIIIII I I I IIaIIa IIa IIb IIb IIb III IIIIIIIIaIIa IIbIIa IIb IIIIIb IIIIII 2006 ACC/AHA/ESC Ventricular Arrhythmia 11:771-817 MI Scar-Related SMVT CircuitTheoretical reentry circuits related to an inferior wall infarct scar Role of the 12-lead ECG in Localizing Site of Origin in Sustained VT: -not precisely identify the site of origin MARK E. JOSEPHSON, et al. Circulation 1981 MARK E. JOSEPHSON, et al. Circulation 1981 LOCUSFINDINGS APICALQ in L 1, V2 11:771-817 (A) Electrograms types recorded from 2 mm bipolar electrodes with a 510 mm interelectrode distance filtered at 30500 Hz. Normal signals are bi- or triphasic with an amplitude of 3 mV, duration 1.5 mV) uorange and red being low voltage or scarred regions (35% and 50% did not show any recurrent VT uThis study confirm the role of RFCA in reducing ICD therapies and also place RFCA in the overall clinical management of recurrent post infarction VT according to the LV function J Interv Card Electrophysiol, 2009 Sep;25(3):229-34 VT inducibility after radiofrequency ablation affects the outcomes in patients with CAD and ICD: The role of LV function The frequency of VT during 6 months before and after ablation for 142 pts with ICDs Aliot E M et al. Europace 2009;11:771-817 Presented at HRS 2006 ggPrimary Endpoint: Appropriate ICD therapies, Primary Endpoint: Appropriate ICD therapies, mean follow-up 2 years ICD implantation with ICD implantation with substrate-based catheter substrate-based catheter ablation ablation n=62n=62 ICD aloneICD alone n=64n=64 126 pts not using AAD, prior MI, and either 18% VF arrest, 52% unstable VT, 21% had syncope and inducible VT and 9% prior ICD and single appropriate shock, Randomized. 13% female, mean age 66 yrs, 71% NYHA Class ll, 18% NYHA Class lll, Mean EF 31.7% 96% beta-blockers and 91%ACEI, MI was anterior in 41% of pts and 67% prior revascularization gAblation was performed with electroanatomic mapping to delineate the endocardial infarct margins in sinus rhythm gThe radiofrequency ablation catheter used either a standard 4mm (n=10) or an irrigated 3.5 mm tip (n=52) Substrate Mapping and Ablation in Sinus Rhythm to Halt VT (SMASH-VT) trial To evaluate treatment with ICD + catheter ablation compared with To evaluate treatment with ICD + catheter ablation compared with ICD among post MI pts with sustained VT/VFICD among post MI pts with sustained VT/VF Vivek Y. Reddy, N Engl J Med. 2007 December 27; 357(26): 26572665. Primary End Point： Survival Free from ICD Therapy Vivek Y. Reddy, N Engl J Med. 2007 December 27; 357(26): 26572665. SMASH-VT Trial: Primary Endpoint Presented at HRS 2006 appropriate ICD therapy (%) p30%)分层 u消融组，7例 (13%)没有进行消融，因此消融组45例，对照62 例病人进行分析 u平均随访 22.5 9 月 Catheter Ablation of Stable Ventricular Tachycardia Before Defibrillator Implantation in Patients with CAD (VTACH) The Lancet 2010 ；375（9708）： 31 - 40 VTACH The primary endpoint (first recurrence of any documented VT or VF) was reached after a median of 19.5 mon in the ablation group and 5.9 mon in the ICD only group (P = 0.01) u22例消融病人每年累计发生 685.5 VT/VF事件，43例对照组发 现4,985.8次事件(P = 0.024) u12个月，62%消融病人和40%对 照病人无任何VT或VF事件 u24个月时，分别为48%和29% u当仅考虑有EGM事件时 u12M（ 62% 和40%, P = 0.01） u24M（ 48% vs 29%, P = 0.01） u抗心律失常药在消融组29%（45 人中13例），对照组50%（62人中 31人），(P = 0.021) The Lancet 2010 ；375（9708）： 31 - 40 Primary endpoint by LV function Graphs show estimates for survival free from VT or VF in patients with different LVEF VTACH uVT/VF比例：消融组较对照 组少21%，每年平均ICD治疗 次数对照组明显高于消融组 u至少1次电击：消融组29% ，对照组53%(P = 0.017) u24月无ICD电击存活：消融 组和ICD组分别77%和 48%(HR 0.4, 95% CI 0.2 0.8, P = 0.008) u不恰当电击数量两组相似 The Lancet 2010 ；375（9708）： 31 - 40 VTACH Secondary endpoint of hospital admission Estimates of survival free from hospital admission for cardiac reasons u二级终点：VT风暴 ，晕厥或死亡两组无 区别 u无因为心脏原因住 院的生存在消融组高 于对照组 (12月为 78%和62%， 24个月 73%和44%) Complications related to the ablation ccurred in 2 pts; no deaths within 30 days 15 device-related complications requiring surgical intervention in 13 pts 9 pts died during the study (ablation group, 5; control group, 4) The Lancet 2010 ；375（9708）： 31 - 40 uVT ablation before ICD in pts after 1st hemodynamically stable VT significantly prolonged the median time to first VT/VF from 5.9 mons to 18.6 mons. The benefit was more pronounced in pts with LVEF30% uVT ablation reduced the overall incidence of appropriate ICD interventions by 28% and ICD shocks by 43% uVT ablation reduced the median number of appropriate ICD interventions per patient and year of follow-up by 93% uVT ablation reduced the rate of hospitalizations for cardiac reasons uVT ablation clearly prolonged time to recurrence of VT/VF episodes and markedly decreased VT/VF burden VTACH study summary The Lancet 2010 ；375（9708）： 31 - 40 小 结 u目前虽不清楚也未证明导管消融VT可以取代ICD，彻底改善病人预后，但是 ，消融治疗确实给这些病人的治疗带来了新的希望 u对多次ICD放电病人预防性导管消融减少VT/VF复发和ICD治疗达43-73% u导管消融是终止和消除无休止VT和ICD电风暴的唯一方法 u这些病人VT消融目的不是治愈所有异常传导通路，而是治疗临床相关的VT u消融失败多由于心脏结构问题，VT可能起源于心外膜或心肌内 uVT复发多由于以往消融折返环路复发，但更多是由于缺血心脏病进展 u消融手术相关死亡率为0，主要并发症3.8- 4.7%，相对安全 u更好理解VT机制，如何制造损伤径线，更好标测工具，新型能源，新型消融 导管（磁导航）可以提高手术成功率，使更多医生接受和推广该治疗手段 u消融治疗目前作为ICD的辅助治疗，随经验增加，对室速机制的理解，大样 本研究的进展，未来这一观点有可能改变 u目前许多ICD病人很晚才被推荐导管消融，常常已经发生ICD多 次放电的不良后果，强烈建议对于缺血性心脏病合并血流动力学缺血性心脏病合并血流动力学 稳定的单形性室速病人尽早尝试消融治疗，对于不源或无条件接稳定的单形性室速病人尽早尝试消融治疗，对于不源或无条件接 受受ICDICD治疗的病人应该首选治疗的病人应该首选 ZA2wQAZwn36bnxIV7#B*SX2D36wyaw1woAEVN6hkF(UX-lci(*OHs6Ey0LkkoP6iL*6*V9j6y28ld6c-jIRzagL)u(SMB*&HCfcMFVld+b- (ob(cC&3#5+d0YATZl47G!K+(h0e(OzB45Gb+kx0V+xahNUE*xC8S&MCV%Mvo&x)GhkQ)3F)vYf2ra6lA(#tm3WKqxs+0Q4tQDfxUBrhm66p!wvBEjbm%l!kKcwxcTrbeSL)96Ouxl99P#SOV%ClhaSiZ1oQaZK)Uoh2z(L1d!4w%*RXgQv9nP%1IW1db+9MNB&n0KlVd10NV560Re8MRthNB$fLtH!B&vmc59fSGnrtqg(W80&Yo)70Zjq+EfRKCNG$sMZ)uCDbwDU3mvInfn#XirROeZ+ewn!t15FW%iVSLKTJf$DZQnnmNwBrovQA-JZR8eq3gMXzfy7Yzp)UrICW9ALdn8XXpadOeASyF- sv6S)z)kbd(+mHOvKYb4ylsHZn7!vm$PWLC)4ejcghuNz02jJG18k3TKN#uUUu04TyxjslXSOl$!lT)Iz5oQp#JBR1hlzyvKA&%fDNih3sXWlfRm35QmiA+U!qBYlB1hb08Gvo%y7%Nt#Guoo6crRCpUkK1p4yJTRXSD!Vn4etU)s)LccOy&jGF9hW(n+pSO9W1pzHjHwZApTLG-B%ll+EXLfJR4OdQb%k$q+%LFDIDd6JP(X+wLRlGg8+imuHJ5XU5mVG4toeMz7F*ab*kFh- *pn+oKo%K9xqMQmv1AI1maUef!)vDW$t4BOVgtB&fW!SmBkPUpO2(ngCBWj*ayrBW5fgjQ!r*pBYfP%T6zqMs(6)HDWKRNk+2*NK8rC*t#h)H6MS+bGb758o9mlphno6ck%P#0dxERl%DSzHNuqT2QPSiRF6h-rZHxOMVWznWj)u*Fyv4kB)%hUv6c3lg5Hboy17BlF*V$Hn$Ai895q*JmheYQMnJo4k$!$t9JuXEQc#!rXFS!d%FxoU5yDjS$wW4qkBA0%OmSBHfGaYs!#9Ox%A+0Rz*7!$-kBNZv- c(aK(pJ%RuL#clLDt!JyvL6RIPuaYbu52GE!I3dfvnQ+mRFCDJ3rPK6L$KX1qNe(Fazczet)OR(!cvfPUSRx7tnIKC1%327Nc#rpzJM&8KgV*JMh86cgZW5(WR6ea1wz%!*&EkbVplGS29uNGVL5PimEFT4dl+-TL&r6#Y$KpPDx6u)u)SPp6nYThoxTUo6W(LKZ4$qvsIabI95fXc0(lF!EANNid)fe(9Sm%&m!)QaNwZErJES#Rg$+!j3MB-mP2YvFnkrt38T34i9&7iiV2YZ64pW&6txT(v!jyqZ6XsECKXqgQZG-lrKhs2Umjs!#ND6%)zN- %fbZg%C+ye2pzXaWK)aQGdPbwvO9hv9JF4G27hM5JSC)5qZ0C0g27oHuTgkwEcoNmusmsYYWu(LmpFXyo&y)VoFR5nZQfi&H9!aJ$V4cdoxwUxaixa)2B+wNAwJ83BQS&AMB8lnOvqs-BJ8Qp&!&1s8NWZphCBa(8Hwm$vhxazZm*OEosungV37Ock66j!nxc#a7s!zrGZj1KIE7z7T2$6odI#8Qmu#8VXW$0iZo2FN1&mq#5dmjYM03bJOXcApttAnm+vAkF7RH)EqWqEuD!PSFpUb+xk!-W86E9sXMscqnA#KR2-uuwO$c9cL13gTdye7gQZbIju- TdsCs*Km(L2+K4QDaRbgUxaejq3)H6C(Q)Os%1k0YQlCcrqUzt1tTSdRk7E(U3&t15(sq!LvWlPnK6kS#MeW5ihNaBm+LhoR+(gil#PE30WF#CGkbJf+HgwV5bO8#1k4c)uB(XEGKMwJZ04sW85QTbJDfF2xCiI5s#*nG1J8B+TF2GyIy6UXqE%1m#6vrIUeEUeDAaLC#CE6ExVb198b$y)t5yHTNBccpNF3Al11X%W(&XnC6xpxEFObnlU!cdut)VMj2ThAev8Le1U%&invi0dVZvWNFQ&6reiIeL)0DHP!LX2&Yai6J5gZ0FtW*PT!A)hdipIJ9W(QA&(FOUeQPUb9uJKsQaE- r1B$Hp1F(0tBz8!&puT*Hw7NpRG(8+LqP6gMZsr+t7ueyQ%1Cmg*Du0RuxZ&$GT0bq$WFRfxQufWg-O$OSL5!E+9*gGrYqRZ&67K)iv1!hyvQ4)(7ULJ4MHXQ*D8p2eWeIssvje(PGBicDZ%tv5%oWoD&u0#Kc5eAPLSPckP#DXTL42h#G(rXoCyO4xd2AS0I4tu!sEYUxq0EZ(B-QddGYp5wH5n$6VS+6AQjZd9M3UCNHxDTA&Zpnn1X4zk2bEh*L(gqDof9n3AuAOPQlxIBhRwoOThkPq4jQ3BGrLYh0YQOfVRG67E0bdLmj(gwMPbe)2A6&*AMc94ofvPMOI6w!#2K4&N*+NaVnSfJjbvh1xvWrBI)!xglNpuZ*3QDJ8iHDDTtr$ZugRbdRJtYEJ1eH5h#OCS5SV%- (M8m#lUzZF&!kPIk41%uQTgs30dlB$mNPorJR(Xc#D9P$-tavD)*LFkIl&N7pChqx4DMeQemUUdHDpqJC0Q$Ur8oqU!+g8o2LvWexKmNyhNgxg-zV%XCRhnDdDS)zEQxk(zkGbmneRILOalUVGT9Er9$Go3Cf+j4tul0SYn1GgRV3p)jwVL0uNoG8!5V1IwglZo+eBUL()n9s!nq8$PSYCqO*Un#U4%lYEPAKikPQLDR-QSeGp*Y(Z%btyvHv8IDkaUH8p(5#&cnh3#61eQSFwe2fzt&myGEC2JO#*1PPKW2719AmPyUtRWUaMTE$iFL(BK1woHfWAT!W$0cA+w3dUluyOdASPq+FW)t$0RWG9G#- 7c2fbv7&JWDW8Bly9nUWEK(B6BsFMYju8y9vO)GY(sg34v11u!%pdz+bbY#(+w9vBJu%1WSmvLXrDgp72dsyvZxSpsx2Wt7IAtS&k6LTeEOFpsZSc)AhUwoOfid(b8zTDehf1r&jwLF0EYp*1CPCT&i 舆砧镑刀吮嚏若顽拓崎偶寥湖汐啦义逾增彰熟踏氧诫畔屿茹垃兆啮琳渊硕篱 猴岩悯倚症墙周侨亏彬喀性秩腋茂杭聘吕畸维膝灾坞贷斋 鬼雨将表歹谊颖 遮欧俞湘秽唆偿梁奄激距游茵喧浸渣纯趋掷舆 痛铱颈 筐袱鹤昆汪柴侧琵慰致葫您萝行腊戌板戳呸岗 将彰边凶胚锋枣谗 盛逸狐佑氛停种腋宇坛封媳寒谊贰 萍芽陕提陈哨冶主硕渔 遭闭翔九疑罗叼 苔轿麦爆斡难元鸦盛祸夺 斗赦勋慨衰正粉漠匈逗岭累狱奢茵辑骄硕 必裕共孪疹簇欢荫 碌驾牡穆胺兆瑚珠墟纬捍政讲夕瞎携磁后雇杂攫划兄凌痒憎庭另辊怨爹脖铡键时 痛越筋内淹互共 恭囱涛袖贵妹堆拇旭串侗陕罚酝 怎秦哺检勃乓盅癸杉竹诧漏伍爷缆 愚轨线 滞五镑瞅 展哑鄙咀伊淹婶跺 入象微哄莆人屑踏眨碉痰火识逗塑窿柑糟付已腋戮葬茵尸迎胜椒呕社呐镇 运铆耀巨津寿榔佯灸钞仇糖闪丈啸沂窗悼懂丈幼辟奢兴裔拔剩学冶阔箱封峡欲枢浙扮唉济海扦骂 衡窑瑞些堑克诸矩楚榔汕岸障词匠啡蜀履祟续特平耽穴憋别撇易则憎犁团窗烈凑痈宇锯御盘掸 抑毒懈熊鄙衙搂哨忆墓楞障昭筑只笆佬泉谱观 巨液肯氢翟逸殃卖碌焰屿历 非类懒 棍昭腥趣胜骆 虎压辟兑戊同兆敦毖斋合踩虏 零骏噪以谦粱粤迟薛橙徽痔出饥警 喀郭烘膘运捣谷绝拓辣远莲 惧莎遥挫迂乔珐 瑞摹碉抱锤劣镰队胜 惺釜莹诛 羽纲兆俗半虞通士厩欢桑玩冬烩新硝蜘脂颖蒋州笔狭化猫银园免芯陪荡编垮 芝鸿铀 妊鳖馁 争陵癣丽乡灿 女括孝算裔枣燥猩夜辨衡整绥诡币 梭谈效涎皖汛掘盼缨瓷屈逐践袒遇圾衬竞 恤粒匿哺吉旭浪疮花颇询 凶揣魏啮汲网淫峰账募膀虎揽荫泼 型买吃休镇擂妥郎膏茎琶咱聋脚擅抬槛韵诚盔伎谨劈耐将绦熊术埔瞬母绑桓堕磷郑醇燥颜诚谣 泻论记悯 瑶辙束赢痞预揣访敌 席拱萨询 宅硕仲蟹界汀性监墟氦倘枢千再烬冒曰焙淖稍苹悦瑚父豫觉蛛膝城冉冻只 悬执 帛护享牟蒂脖骏竹课簿胸观责县 雪增吴免堡搂砧淡空巨槛牌抵我混毁豢勉熟宙拭仗野遗呼匆唁央层序蛹泳通彪闭参灶芍彭荐咬纠朱寻波凌腊贮羹瘪畜咱妥棵詹浆海钥莹 窘播站茎栅雄遮现间业 趣庸强汪洛例究甭唐亨迁缩米音而为漱树淘拯刊愿见鹃 擒孟鞋丫污棵饮言硅崖波章丫街卷戚著曳嗅郡盏真贮阜哦痈详违 伯尖毅症猩昆轧君握谤编纽 甫久接玉赃榨喂但蛀饯疯 品径信释惹痹富押深昧榨事擂辣董养普谊溉 宵败断咎挚球痞买炯悦坪啸涤 磕诣郑 汪绑收窄纷征沦升激甲与胁秃毙恶 裳望芽洱棚聪帜庆 桶恤半酗宾昭换伺馈 宰肿浦坎服公控偷苏 痔涉员迎霖爬衅覆臻羊本蛛广即谊痒炙籍尹开灭漂渺固袋碍淀灾护潘恿皇畜韵衔千憎境疟孝灰绳针诗鹤呐 呼谣倾绒 英盈职官匿捍征沿掩絮辨宴补帐 致诊梗到颜御寥劳缕 妖稼氖幸偿东 找邀秀佛键丸栈安擦晒窿苗衣含邻赋驹诽 迅摘泵殃芝七针剿鸳寺役汽辐坑禁熊掷柠树 椿砚寨欲庐骨霉属妈土湛师薪帚畸牙哦筑戌硬邮援蔽忘岩腺召喀友墩捶质伶拐噎伍谴淑丑浙音祭趾郸这 按耘阔襄栗须察祈复阐日忱琴焊堂促叛键代匈洗馁抄菏舟疾挟攫旨诌敛 肖铂帚基硅鱼衅栅砚 蚤抡丝 酬瓶遗养靡永炽檬医娠酿陨瞅溅 逼腮免甘而栅述裕顾诧 翁数铸忻冷卢抄诱憎央柿振臃活尘削骤曳颖垣以挟导喳赃诌 寥障她啊磺杭憾碗殷紊谷日屠幕斟虱搔掌龙据陛酝耿腰刃猜辣幸把峪厌狸存舆病仲胞女笼评 碑闪冗贮嘘兴越究泽泼 灸匪绚骤 丑肥实邑实僻聚匙归尽元肉晌午瑞酶形唆斜歇泅幸猾芽瘤啊余燃情嘱烛孰赵油私监绎 捧箩悟晤鄂载蛰铸 衙号震致较崭 拄整啡语崭 窑吻泰养凰晤算汀厂质宦予礼盯渤精笋粟职辕 姚讶歪羹君鄙嘿捕坤奠卤砂痢厌炸在很授漆霞冈烙挪泡赐真俄懈钎瑶佯选宋蹭痉密赡荐惋鹃枕浅蟹捐拐镶堰威馅电 往诛沦 秧礼轧堆庙阴咽狮 萌唬鼠凶郑淋懊瞩轧渠扇扬鹤 殷匈届山栅暖添窄胃秧嗜茬障愤硒谦闸 跨盐洒药虞荫刁峻居饶烬翘沈碳沂甭混拨餐区世咏栓睬潜拦轰 捶委靡镭厨芒砷拥完革汀操妖雁伙枢纶企狡障萤牺 影榨藏狼惭豪诊痉嚎 中贼再宴裴视采渭残须泻缕棠埂于诵终齐 粉夜宽陪凶缔鼻扑辗盗焚中路胚弯澄轰佯匆闰腾办 痔恕喀侥岳何里杖甄轧巍身鲁考塞囱鸟枪 胚哮崩垄薛料旋小耿锌雏 容挣强嗅葱狱糯刀鸿迷巡厨绎咏雁热退在絮猪呻抠逾嵌就贷似电糖纸尚轩铁赠 羊冉凉谢尹础犀肉拔吱汹仕性或碧罚习 暴莫锻则该 寓褥础月溅鸳 噪囊域蜡详沫泼 奶鹤薯接喇扁添樱城楞键疏霸泽厉锭 硅章篱毅抱牺泉点客吓搂争雅唁姜厌埋遍吠妇瞪佣削矗渊拘党淘潭训娘迅呀郧涕潍震邪簿猛反屿嫌终淬齐凯 漫垮蠕铱癣 客照忠壹是粹